Protocol No. Ptcemf-gd-004, entitled A multicenter randomized placebo-controlled Phase III study on the safety and efficacy of deflazacort (emflaza) In patients with Limb-girdle muscular dystrophy 2i (lgmd2i)
|Effective start/end date||3/8/19 → 9/30/24|
- PTC Therapeutics, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.